SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
ImmunoScape presented compelling new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Demand for coins, bars continue in main markets* Gold to range from $1,360-$1,405 -technicalsID:nL3N0D6538* Coming Up: U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results